Avian Flu’s Relentless Toll on Holiday Poultry

Roasted turkey garnished with greens on a silver platter, alongside bowls of mashed potatoes and stuffing, dinner rolls, and a small decorative pumpkin on a wooden table.
Image courtesy of Phys.org

For the third straight year, avian influenza is decimating poultry flocks, leading to soaring prices for fresh turkeys just in time for the holidays. The virus presents a relentless challenge for producers and consumers alike.

As the scent of roasting turkey begins to waft through American homes, a familiar, unwelcome guest hovers over the holiday table: avian influenza.

For the third consecutive year, a highly infectious strain of bird flu is casting a long shadow, a relentless specter carried on the wings of migratory waterfowl.

It’s a sight that unnerves poultry producers like Cliff McConville, whose Dundee Township farm, All Grass Farms, sees wild geese landing in fields shared by his turkeys and chickens.

“We raise them outdoors,” McConville explains, a pragmatic acceptance in his voice.

“They’re going to mix with (wild) birds. So we just have to do our best to keep them healthy. … That’s worked for us so far. Knock on wood.”

McConville’s good fortune, however, is not universal.

Across the nation, particularly in larger turkey-producing states, the past couple of months have delivered a devastating blow.

Nearly 2 million turkeys have been affected by bird flu since August, a staggering 24% of all new cases in commercial and backyard flocks, despite turkeys accounting for only about 2% of the U.S. poultry inventory.

The numbers are particularly grim in Minnesota, a powerhouse in turkey production, where over 716,000 commercial turkeys have been infected or exposed this fall alone.

This latest surge isn’t just a biological crisis; it’s an economic one.

Experts are forecasting higher prices for wholesale and fresh turkeys just as families gather for Thanksgiving. This isn’t solely due to the virus; a nearly 10% drop in turkey meat production from last year, coupled with rising labor costs and a general dip in consumer demand throughout the year, has created a perfect storm.

Those planning to buy conventional frozen turkeys might find some relief, as many large retailers stocked up months ago, before the fall spike.

But for those who cherish a fresh bird, the outlook is less rosy: wholesale costs have shot up a shocking 81% from last year, with retail prices for fresh turkeys jumping 12.5% in the second week of November.

David Anderson, a professor of agricultural economics at Texas A&M University, calls it “a huge jump.”

The ripples extend beyond the Thanksgiving centerpiece.

Last winter, a bird flu outbreak sent egg prices soaring to record highs in March.

While egg prices have since retreated, cases are surging again among egg-laying chickens, with approximately 5.8 million commercial layers affected this fall.

Since 2022, over 183 million commercial birds have been lost across all 50 states to this highly pathogenic strain of avian influenza, a disease with no treatment, spread relentlessly by wild birds during their seasonal migrations.

“The Upper Midwest, in general, is experiencing a very active, highly pathogenic avian influenza season,” notes Dr. Michelle Kromm, a Minnesota-based veterinarian specializing in poultry and public health.

This particular strain, she explains, is “very unique in the fact that it’s sticking around,” making it a persistent, rather than transient, threat.

Jada Thompson, an associate professor of agricultural economics at the University of Arkansas, paints a vivid picture of the industry’s struggle: “It’s like standing in the middle of the ocean and getting hit by a wave.

So every time you get hit, and you think, ‘I’m recovering,’ you get hit by another wave.”

The loss of breeder hens, which take a long time to replace, has particularly long-term implications for the supply chain.

When a flock tests positive, the USDA’s “stamping-out” policy dictates zero tolerance: all infected and exposed birds must be culled.

While the government offers some financial assistance for depopulation and cleanup, it rarely makes producers “whole,” creating significant cash-flow challenges.

Biosecurity measures have long been a “normal course of business” for large commercial operations, but this strain is so contagious it has proven difficult to contain even with standard precautions.

Adding to the tension, mass firings across federal agencies, including the USDA, have meant less experienced staff are now conducting biosecurity audits.

“You have folks coming out to audit a turkey farm that have never been to a poultry farm… and so they’re coming through with a rubric and having a conversation and checking boxes,” Kromm observes, hinting at the friction this can create.

The prospect of a vaccine, while offering a glimmer of hope, is complicated by international trade concerns.

Importing countries fear that vaccinated, asymptomatic birds could still spread the infection.

This creates a frustrating paradox for domestic producers who would prioritize protecting their flocks over export markets.

“Those conversations have to be had with trade partners,” Kromm explains, acknowledging the complexity but also the excitement around vaccine research as a potential “added layer of protection.”

For smaller, specialty farmers like Cliff McConville and Joe Wanda of Wanda Farms in Harvard, Illinois, the landscape is different.

Their pasture-raised, organic turkeys sell for a premium ($7.95-$10 per pound), appealing to a niche market willing to pay for quality and ethical rearing practices.

These farms, often less integrated into the vast commercial supply chain, can sometimes weather the storms more independently.

They diversify their income with beef cattle, broiler chickens, and pork, recognizing the inherent risks of farming.

“We just recognize this is the risk of being a farmer,” Wanda says, “that there are external factors of disease that, potentially, we could get.

We just, I guess, gotta pray that we don’t get it.”

As the holiday season approaches, the bird flu continues to redefine what constitutes “normal” in the poultry industry.

It’s a stark reminder of the delicate balance between nature, commerce, and the dinner table, a challenge that farmers and consumers alike are learning to navigate, wave after relentless wave.

The Checkup

A weekly newsletter focusing on the most important news in health and biotech.

More News

At Global Business & Economics Journal, we contribute to the  future of business and technology with news,  innovative research, expert insights, and thought-provoking analysis.

The latest from
The Checkup: Our weekly biotech and health email

Sign up to get The Checkup weekly in your inbox.